HRT Financial’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
IAIM
HRT Financial's ONCY Position: Q3 2026 in Review
HRT Financial reduced its Oncolytics Biotech (ONCY) stake by 70% in Q3 2026, selling an estimated $72.2K and leaving 37,332 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #4473.
HRT Financial first reported a position in ONCY in Q3 2025 and has held it in 5 quarters since. The position peaked at $119K in Q2 2026. 77 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.
- HRT Financial held 37,332 shares of Oncolytics Biotech worth $24K as of Q3 2026.
- HRT Financial sold 88,993 Oncolytics Biotech shares in Q3 2026, an estimated $72.2K.
- Oncolytics Biotech made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4473 holding.
- HRT Financial first reported a position in Oncolytics Biotech in Q3 2025 and has held it in 5 quarters since.
- HRT Financial's Oncolytics Biotech position peaked at $119K in Q2 2026.
- 77 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.
Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.